ADUS

AI Memo

Addus HomeCare

As of 2026-10-01/Confidence medium/Horizon 6‑12m

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-10-01 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

—

Confidence

medium

Horizon

6‑12m

Key catalyst

AccentCare personal-care acquisition closing • 2027-03-31

Base target: $122 / p=50% prob

Biggest risk

Regulatory delay, integration expense, wage or reimbursement pressure, and revolver-funded acquisition costs could erode the expected benefit. The deal is agreed, not completed, and management's revenue and accretion estimates are forward-looking. [#8-K-2026-09-14] [#PR-2026-09-14]

Invalidation

Break below $88 or thesis failure.

What would change my mind?

Q2 growth, higher adjusted EBITDA and operating cash flow provide an operating base for the proposed AccentCare expansion. If the transaction closes and management's anticipated accretion materializes without significant integration costs, earnings capacity could exceed the base scenario. [#SEC-8K-2026-08-03] [#PR-2026-09-14]

Research note

Recommendation

—

Confidence

medium

As of

2026-10-01

Base target

$122

p=50%

Bull target

$140

p=25%

Bear target

$88

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Organic growth and cash-generation validation
Acquisition integration and earnings contribution
Q2 growth, higher adjusted EBITDA and operating cash flow provide an operating base for the proposed AccentCare expansion.

BearKey bullets

Addus expects to fund the acquisition with cash and its revolver, creating financing-cost and balance-sheet sensitivity.
[#PR-2026-09-14]
Integration costs or weaker-than-expected acquired margins could prevent anticipated accretion.

WatchKey bullets

AccentCare personal-care acquisition closing

Summary

High-level snapshot

Recommendation

Model confidence

medium

Timeframe

6‑12m

Asset

Equity

Trigger

Base case: $122 (p=50%)

Target spread vs base: +15% / -28%

Scenario probabilities

Bull Target: $140 (p=25%)Base Target: $122 (p=50%)Bear Target: $88 (p=25%)

Commentary

Company-confirmed Q2 growth and the September acquisition agreement make the evidence directionally positive, consistent with the packet's positive deterministic prior. The deal has not closed, and post-announcement analyst revisions, options, short-interest and social measures were unavailable. Numeric sentiment fields without observed data are unverified placeholders and should not be interpreted as measured readings. The $110.54 anchor is a September 30 adjusted close, not a verified deal-announcement price reaction.

As of 2026-10-01 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Organic growth and cash-generation validation
Acquisition integration and earnings contribution

Scenarios

Bull Target (Scenario probability)

$140 / p=25% prob

Base Target (Scenario probability)

$122 / p=50% prob

Bear Target (Scenario probability)

$88 / p=25% prob

Analysis 2026-10-01 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

0.25

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2027-03-31
AccentCare personal-care acquisition closing
Addus agreed to acquire AccentCare's personal-care and community-care operations outside New York for approximately $275 million in cash. The company estimates roughly $280 million in annualized revenue from the acquired operations. Closing remains subject to regulatory approvals and other conditions; no closing date was provided. [#8-K-2026-09-14] [#PR-2026-09-14]
Prob 75.00% • Move 6.00% • Priced-in 55.00%

Short-term Catalysts

Next few weeks

Organic growth and cash-generation validation
2026-12-31
Q2 2026 net service revenue rose 8.0% year over year to $377.4 million, adjusted EBITDA rose 11.9% to $49.2 million, and operating cash flow was $40.0 million. Sustaining those trends while preparing the acquisition would support the thesis; the monitoring date is an estimate, not an announced reporting date. [#SEC-8K-2026-08-03]
Prob 65% • Move 3% • Priced-in 65%

Long-term Catalysts

Months to a year

Acquisition integration and earnings contribution
2027-12-31
Management expects the proposed AccentCare transaction to be accretive and to expand Addus's personal-care scale, particularly in Texas, Illinois, California and Arizona. Realized margins, financing costs and integration expenses must validate that expectation after closing; this date is an analytical monitoring horizon, not company guidance. [#PR-2026-09-14]
Prob 60% • Move 9% • Priced-in 35%

Risks

Addus expects to fund the acquisition with cash and its revolver, creating financing-cost and balance-sheet sensitivity. [#PR-2026-09-14]
Integration costs or weaker-than-expected acquired margins could prevent anticipated accretion. [#PR-2026-09-14]
Reimbursement changes, caregiver availability and wage pressure could constrain home-care margins. [#PR-2026-09-14]
The AccentCare transaction requires regulatory approvals and satisfaction of closing conditions; no completion date was provided. [#8-K-2026-09-14]

Peers

Symbol	Summary
MD	Pediatrix is a healthcare-services company of roughly comparable market capitalization, but its service model differs from Addus's home care; it is only a loose valuation reference. The packet does not establish two direct operating peers.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-10-01

Loading AI feed…

Symbol

Summary

Pediatrix is a healthcare-services company of roughly comparable market capitalization, but its service model differs from Addus's home care; it is only a loose valuation reference. The packet does not establish two direct operating peers.